Expect Equity’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
Expect Equity's IART Position: Q4 2025 in Review
Expect Equity sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 92,105 shares — an estimated $1.32M sold.
Expect Equity first reported a position in IART in Q4 2024 and held it in 4 quarters. The position peaked at $2.09M in Q4 2024. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.
- Expect Equity reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
- Expect Equity sold 92,105 Integra LifeSciences shares in Q4 2025, an estimated $1.32M.
- Expect Equity first reported a position in Integra LifeSciences in Q4 2024 and held it in 4 quarters.
- Expect Equity's Integra LifeSciences position peaked at $2.09M in Q4 2024.
- 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.
Based on Expect Equity's 13F filing for Q4 2025, filed 17 Feb 2026.